Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

By P. Braitstein, M. Brinkhof, F. Dabis, M. Schechter, A. Boulle, P. Miotti, R. Wood, C. Laurent, E. Sprinz, C. Seyler and 5 more. The Lancet, 2006

1,166 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007, neutral): “) Treatment programmes with passive follow-up were excluded from subsequent analyses’’ [116].”
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa (2008, background): “This analysis found that early mortality following initiation of ARTwas several-fold higher among patients in resource-limited settings compared to that of patients treated in high-income settings, even after adjusting for baseline immunodeficiency [12].”
Prevention of HIV-1 Infection with Early Antiretroviral Therapy (2011, neutral): “HIV-positive man, HIV-negative man 18 (2) 19 (2) NA NA”
Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review (2007, background): “It should be noted that the Antiretroviral Therapy in Low Income Countries (ART-LINC) collaboration has recently reported aggregate 1 y mortality and loss to follow-up rates for 13 cohorts in sub-Saharan Africa [5].”